These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 25577885

  • 1. Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report.
    Mixon B, Mixon J, Isbey EK, Sprinkle S.
    Int J Pharm Compd; 2014; 18(5):370-7. PubMed ID: 25577885
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC, Lin JM, Chen WL, Tsai YY.
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [Abstract] [Full Text] [Related]

  • 3. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, Kuwana M, Tsubota K, Ikeda Y, Oguchi Y.
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [Abstract] [Full Text] [Related]

  • 4. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V, Gehlsen U, Sauerbier L, Holtick U, Engel L, Radojska S, Petrescu-Jipa VM, Scheid C, Hallek M, Gathof B, Cursiefen C, Steven P.
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.
    Azari AA, Karadag R, Kanavi MR, Nehls S, Barney N, Kim K, Longo W, Hematti P, Juckett M.
    Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960
    [Abstract] [Full Text] [Related]

  • 6. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
    Zallio F, Mazzucco L, Monaco F, Astori MR, Passera R, Drago G, Tamiazzo S, Rapetti M, Dolcino D, Guaschino R, Pini M, Ladetto M.
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
    Na KS, Kim MS.
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
    [Abstract] [Full Text] [Related]

  • 8. [Dry eye in graft-versus-host disease].
    Fei WL, Chen JQ, Du X, Liu YH, Sun MX, Lin JX, Weng JY, Luo TZ, Yin DM, Luo XY.
    Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):686-90. PubMed ID: 14766066
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The clinical efficiency of calf blood extract gel on moderate to severe dry eye induced by chronic graft versus host diseases after bone marrow transplantation].
    Liu J, Liu ZG, Shao Y, Chen JY, Li W, Lin H.
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):32-6. PubMed ID: 23601463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation.
    Ivanir Y, Shimoni A, Ezra-Nimni O, Barequet IS.
    Cornea; 2013 May; 32(5):e97-101. PubMed ID: 23187163
    [Abstract] [Full Text] [Related]

  • 13. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
    Ogawa Y, Dogru M, Uchino M, Tatematsu Y, Kamoi M, Yamamoto Y, Ogawa J, Ishida R, Kaido M, Hara S, Matsumoto Y, Kawakita T, Okamoto S, Tsubota K.
    Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ocular graft-versus-host disease.
    Hessen M, Akpek EK.
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):540-7. PubMed ID: 22892710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Winiarski J.
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [Abstract] [Full Text] [Related]

  • 19. Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis).
    Mian SI, De la Parra-Colín P, De Melo-Franco R, Johnson C, Barrientos-Gutierrez T.
    Trans Am Ophthalmol Soc; 2015 Sep; 113():T11. PubMed ID: 27507907
    [Abstract] [Full Text] [Related]

  • 20. Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases.
    Sanchez-Avila RM, Merayo-Lloves J, Muruzabal F, Orive G, Anitua E.
    Eur J Ophthalmol; 2020 Jan; 30(1):94-103. PubMed ID: 30585084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.